Financial statements Gbj Pharma
Balance sheet data of GBJ PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 363 369,01 | 136 057,32 | 110 348,27 | 149 871,21 | 176 061,83 | 100 360,35 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 34 630,73 | 14 812,00 | 7 334,18 |
| B. Current assets | 363 369,01 | 136 057,32 | 110 348,27 | 115 240,48 | 161 249,83 | 93 026,17 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 363 369,01 | 136 057,32 | 110 348,27 | 149 871,21 | 176 061,83 | 100 360,35 |
| A. Equity | -360 053,78 | -379 187,16 | -195 798,14 | 149 871,21 | 133 901,83 | 92 783,12 |
| B. Liabilities and provisions for liabilities | 723 422,79 | 515 244,48 | 306 146,41 | 0,00 | 42 160,00 | 7 577,23 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.